Upgrade to SI Premium - Free Trial

Quantum BioPharma (QNTM)

3.55 +0.09 (2.60%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26 *Est.)

Latest Headlines

Form 6-K Quantum Biopharma Ltd. For: Aug 10 August 10, 2026 7:00 AM - SEC Filing Quantum BioPharma gets FDA clearance for Lucid-MS phase 2 MS trial August 10, 2026 7:00 AM - StreetInsider Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis: August 10, 2026 7:00 AM - StreetInsider Form SCHEDULE 13G Quantum Biopharma Ltd. Filed by: AdvisorShares Trust July 8, 2026 5:21 PM - SEC Filing NetworkNewsAudio Announces Audio Press Release (APR) the Advancement of First-in-Class Treatment for Multiple Sclerosis June 26, 2026 8:30 AM - StreetInsider Quantum BioPharma MS drug candidate moves toward phase 2 trials June 25, 2026 8:32 AM - StreetInsider Quantum BioPharma MS drug candidate nears phase 2 trials June 25, 2026 8:31 AM - StreetInsider Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy June 25, 2026 8:30 AM - Globe NewsWire Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy June 25, 2026 8:30 AM - StreetInsider The Quest to Repair What Multiple Sclerosis Takes Away June 24, 2026 8:30 AM - StreetInsider Quantum BioPharma's MS drug candidate nears phase 2 trials June 23, 2026 8:31 AM - StreetInsider Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach June 23, 2026 8:30 AM - StreetInsider Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis June 22, 2026 8:30 AM - StreetInsider Form 6-K Quantum Biopharma Ltd. For: Jun 02 June 2, 2026 11:51 AM - SEC Filing Quantum BioPharma hires IR Agency for investor relations services June 2, 2026 7:40 AM - StreetInsider Form 6-K Quantum Biopharma Ltd. For: Jun 02 June 2, 2026 7:40 AM - SEC Filing Quantum BioPharma Engages Stocks.news For Investor Relations, Marketing Services And Lead Generation Campaigns June 2, 2026 7:40 AM - StreetInsider Form 6-K Quantum Biopharma Ltd. For: May 18 May 18, 2026 6:04 AM - SEC Filing Quantum BioPharma reaches halfway point in imaging study with MGH May 18, 2026 5:08 AM - StreetInsider Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital May 18, 2026 3:00 AM - Globe NewsWire Full Article List